tetrahydrozoline has been researched along with Pterygium in 2 studies
tetrahydrozoline: used as nasal decongestant; Visine is a form of eye drops; RN given refers to parent cpd; structure
Pterygium: An abnormal triangular fold of membrane in the interpalpebral fissure, extending from the conjunctiva to the cornea, being immovably united to the cornea at its apex, firmly attached to the sclera throughout its middle portion, and merged with the conjunctiva at its base. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effect of a fluorometholone/tetrahydrozoline fixed combination on conjunctival graft morphology after primary pterygium excision." | 9.17 | Effect of fluorometholone/tetrahydrozoline fixed combination on conjunctival autograft morphology after primary pterygium excision. ( Agca, A; Alkin, Z; Bozkurt, E; Demirok, A; Gencer, B; Kara, N; Ozgurhan, EB, 2013) |
| "To evaluate the effect of a fluorometholone/tetrahydrozoline fixed combination on conjunctival graft morphology after primary pterygium excision." | 5.17 | Effect of fluorometholone/tetrahydrozoline fixed combination on conjunctival autograft morphology after primary pterygium excision. ( Agca, A; Alkin, Z; Bozkurt, E; Demirok, A; Gencer, B; Kara, N; Ozgurhan, EB, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ozgurhan, EB | 1 |
| Kara, N | 1 |
| Bozkurt, E | 1 |
| Gencer, B | 1 |
| Agca, A | 1 |
| Alkin, Z | 1 |
| Demirok, A | 1 |
| Enkvetchakul, O | 1 |
| Thanathanee, O | 1 |
| Rangsin, R | 1 |
| Lekhanont, K | 1 |
| Suwan-Apichon, O | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Intralesional Ranibizumab on Pterygium Vascularity, Size and Recurrence Rate: a Pilot Study[NCT02342392] | Phase 2/Phase 3 | 36 participants (Actual) | Interventional | 2012-09-30 | Completed | ||
| Role of Sub-Conjunctival Bevacizumab in Post Pterygium Excision Management[NCT01736449] | Phase 4 | 31 participants (Actual) | Interventional | 2011-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for tetrahydrozoline and Pterygium
| Article | Year |
|---|---|
Effect of fluorometholone/tetrahydrozoline fixed combination on conjunctival autograft morphology after primary pterygium excision.
Topics: Adult; Aged; Autografts; Conjunctiva; Demography; Drug Therapy, Combination; Female; Fluorometholone | 2013 |
A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: preliminary results.
Topics: Administration, Topical; Angiogenesis Inhibitors; Antazoline; Antibodies, Monoclonal, Humanized; Bev | 2011 |
A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: preliminary results.
Topics: Administration, Topical; Angiogenesis Inhibitors; Antazoline; Antibodies, Monoclonal, Humanized; Bev | 2011 |
A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: preliminary results.
Topics: Administration, Topical; Angiogenesis Inhibitors; Antazoline; Antibodies, Monoclonal, Humanized; Bev | 2011 |
A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: preliminary results.
Topics: Administration, Topical; Angiogenesis Inhibitors; Antazoline; Antibodies, Monoclonal, Humanized; Bev | 2011 |